🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, double-blind, placebo-controlled, dose-E...
Status
Completed
Location
Allife Medicine （Beijing） Limitied
Start Date
2023-08-24
Trial ID
NCT05993884
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
This study adopted a single-center, randomized, double-blind, placebo-contr...
Status
Completed
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2025-08-06
Trial ID
NCT07083362
Treatments Being Tested
The primary purpose of this study is to evaluate safety/ reactogenicity of ...
Status
Completed
Location
Floridian Clinical Research LLC
Start Date
2023-05-17
Trial ID
NCT05901636
Treatments Being Tested
A study in healthy male and female participants of non-childbearing potenti...
Status
Completed
Location
Research Site
Start Date
2022-09-20
Trial ID
NCT05511025
Treatments Being Tested
The primary goal for this study is to evaluate the safety and reactogenicit...
Status
Completed
Location
Synexus Clinical Research US Phoenix Southeast, Inc.
Start Date
2021-03-11
Trial ID
NCT04813796
The primary objective of this study is to evaluate the immunogenicity and s...
Status
Active Not Recruiting
Location
Baise Center For Disease Control & Prevention
Start Date
2025-09-15
Trial ID
NCT07289542
This research is being done to study the effects of the drug omalizumab (Xo...
Status
Completed
Location
Johns Hopkins Asthma and Allergy Center
Start Date
2007-07
Trial ID
NCT00604786
Treatments Being Tested
Primary Objective: To demonstrate the reduction of low-density lipoprotein...
Status
Completed
Location
Investigational Site Number 392028
Start Date
2015-11-30
Trial ID
NCT02584504
Treatments Being Tested
Alirocumab (SAR236553/REGN727) is a fully human monoclonal antibody that bi...
Status
Completed
Location
Investigational Site Number 840857
Start Date
2012-07
Trial ID
NCT01644175
Treatments Being Tested